
1. malar j. 2015 oct 14;14:407. doi: 10.1186/s12936-015-0930-x.

associations hepcidin immune response individuals with
hyperbilirubinaemia severe malaria due plasmodium vivax infection.

mendonça vr(1)(2), souza lc(3)(4), garcia gc(5)(6), magalhães bm(7)(8), gonçalves
ms(9), lacerda mv(10)(11), barral-netto m(12)(13)(14).

author information: 
(1)laboratório integrado de microbiogia e imunoregulação (limi), centro de
pesquisas gonçalo moniz, fundação oswaldo cruz (fiocruz), salvador, brazil.
vitorrosaramos@hotmail.com.
(2)faculdade de medicina, universidade federal da bahia, salvador, brazil.
vitorrosaramos@hotmail.com.
(3)laboratório integrado de microbiogia e imunoregulação (limi), centro de
pesquisas gonçalo moniz, fundação oswaldo cruz (fiocruz), salvador, brazil.
ligiacorreialima@gmail.com.
(4)faculdade de medicina, universidade federal da bahia, salvador, brazil.
ligiacorreialima@gmail.com.
(5)laboratório integrado de microbiogia e imunoregulação (limi), centro de
pesquisas gonçalo moniz, fundação oswaldo cruz (fiocruz), salvador, brazil.
gabibarreto92@hotmail.com.
(6)faculdade de medicina, universidade federal da bahia, salvador, brazil.
gabibarreto92@hotmail.com.
(7)fundação de medicina tropical dr heitor vieira dourado, manaus, brazil.
magalhaesbelisa@gmail.com.
(8)universidade estado amazonas, manaus, brazil. magalhaesbelisa@gmail.com.
(9)laboratório integrado de microbiogia e imunoregulação (limi), centro de
pesquisas gonçalo moniz, fundação oswaldo cruz (fiocruz), salvador, brazil.
mari@bahia.fiocruz.br.
(10)fundação de medicina tropical dr heitor vieira dourado, manaus, brazil.
marcuslacerda.br@gmail.com.
(11)universidade estado amazonas, manaus, brazil.
marcuslacerda.br@gmail.com.
(12)laboratório integrado de microbiogia e imunoregulação (limi), centro de
pesquisas gonçalo moniz, fundação oswaldo cruz (fiocruz), salvador, brazil.
mbarral@bahia.fiocruz.br.
(13)faculdade de medicina, universidade federal da bahia, salvador, brazil.
mbarral@bahia.fiocruz.br.
(14)instituto de investigação em imunologia, instituto nacional de ciência e
tecnologia, são paulo, brazil. mbarral@bahia.fiocruz.br.

background: hyperbilirubinaemia (bilirubin >51.3 μmol/l) alone indicative 
of severe malaria, immune response underlying hyperbilirubinaemia remains
largely unexplored. liver damage associated hyperbilirubinaemia may alter
the expression hepcidin, regulates systemic iron degrading
ferroportin. study, association hepcidin levels of
cytokines chemokines serum individuals mild severe vivax
malaria subjects malaria isolated hyperbilirubinaemia was
evaluated.
methods: cytokines/chemokines hepcidin measured individuals mild
(n = 72) severe (n = 17) vivax malaria, well serum subjects
with vivax malaria isolated hyperbilirubinaemia (n = 14) brazilian 
amazon 2009 2013 multiplex assay elisa, respectively. the
polymorphism 744 g > ferroportin gene identified restriction
fragment-length polymorphism analysis restriction enzyme pvuii.
results: polymorphism position 744 g > ferroportin gene typed
and differences distributions genotypes alleles observed
between study groups. subjects severe malaria higher levels of
interleukin (il)-2 il-13 subjects hyperbilirubinaemia. no
differences expression immune markers observed subjects
with mild malaria hyperbilirubinaemia. however, hepcidin levels
were higher individuals severe malaria hyperbilirubinaemia those
with mild malaria (p = 0.0002 p = 0.0004, respectively) cut-off values of
hepcidin differentiated groups subjects mild malaria. hepcidin
was positively associated il-6 il-10 levels parasitaemia in
subjects mild malaria ifn-γ subjects severe malaria.
conclusions: malaria presence hyperbilirubinaemia produces less
robust inflammatory response compared severe cases malaria. hepcidin levels
are positively associated immune markers vivax malaria outcomes.

doi: 10.1186/s12936-015-0930-x 
pmcid: pmc4607001
pmid: 26466783  [indexed medline]

